Genzyme Corp. (NASDAQ:GENZ) of Cambridge, Mass., has beengranted two U.S. patents for producing phospholipids.Corresponding foreign applications are pending. The twopatents contain claims to a salt of glycerol-3-phosphate, as wellas methods for its preparation and use in the synthesis ofphospholipids.

(c) 1997 American Health Consultants. All rights reserved.

No Comments